课题基金 / 基金详情

PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS

PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
抗肿瘤/HIV药物的药理学研究
批准号：
3610239
负责人：
ROBERT A NEWMAN
金额：
$3.44万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
1991
资助国家：
美国
项目状态：
已结题
起止时间：
1991-11-15 至 1994-11-14
来源：
https://reporter.nih.gov/project-details/3610239
关键词：
antiAIDS agent antineoplastics antiviral agents clearance rate dogs drug administration rate /duration drug administration routes drug metabolism drug screening /evaluation laboratory mouse laboratory rat method development pharmacokinetics

项目摘要

项目成果

ROBERT A NEWMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Contractor shall furnish services, qualified personnel, material, equipment and facilities, not otherwise provided by the Government to perform assignments for Preclinical Pharmacology studies of Antitumor and Anti-HIV agents in body fluids and/or tissues of animals at know effective antitumor or antiviral concentrations. Task assignments will be issued under this Cost Reimbursement/Level of Effort contract which allows the Government to exercise control in scheduling and directing the studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOCHEMICAL AND MECHANSIMS OF ACTION OF STUDIES WITH
BIOCHEMICAL AND MECHANSIMS OF ACTION OF STUDIES WITH
PHARMACOLOGICAL STUDIES OF ANTITUMOR & ANTI-HIV AGENTS
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
海外基金